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Edited by Peter BrzezinskiAbstract The purinergic receptor P2X7 is part of a complex
signaling mechanism participating in a variety of physiological
and pathological processes. Depending on the activation scheme,
P2X7 receptors in vivo are non-selective cation channels or form
large pores that can mediate apoptotic cell death. Expression of
P2X7R in Xenopus oocytes results exclusively in formation of a
non-selective cation channel. However, here we show that co-
expression of P2X7R with pannexin1 in oocytes leads to the com-
plex response seen in many mammalian cells, including cell death
with prolonged ATP application. While the cation channel activ-
ity is resistant to carbenoxolone treatment, this gap junction and
hemichannel blocking drug suppressed the currents induced by
ATP in pannexin1/P2X7R co-expressing cells. Thus, pannexin1
appears to be the molecular substrate for the permeabilization
pore (or death receptor channel) recruited into the P2X7R signal-
ing complex.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Extracellular ATP plays an important signaling role in
numerous and varied physiological processes. In the CNS, this
nucleotide has been proposed to modulate neuronal and glial
activity [1]. ATP also controls peripheral blood ﬂow [2].
ATP signaling is mediated by two types of purinergic
receptors, the metabotropic P2Y receptors and the ionotropic
P2X receptors [3]. Ionotropic P2 receptors respond to the
ligand ATP or related agonists by opening small non-selective
cation channel. For certain P2X receptors, notably P2X7R [4]
repeated or prolonged application of the ligand leads to the
formation of a pore large enough to allow inﬂux of tracer
molecules typically used to assess gap junction function.
Prolonged activation of the receptors can lead to cell
death.
Two hypotheses have been presented to explain the conver-
sion of the non-selective cation channel to the cytolytic pore
[5]. The pore may form by accretion of the channel forming*Corresponding author. Fax: +1 305 243 5931.
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natively, pore formation may require additional components.
Attempts to reconstitute the pore formation in exogenous
expression systems have been unsuccessful, favoring the sec-
ond hypothesis. While pore formation can be observed in some
cell types expressing P2X7R exogenously, other cells, including
Xenopus oocytes, exhibit only the cation channel activity when
the P2X7R is expressed [6]. Interestingly, while pore formation
could not be reconstituted in oocytes with the P2X7 receptor
alone, pore formation was observed in response to injection
of the cells with macrophage mRNA [7]. These observations
are highly suggestive for the need of an additional component
for pore formation.
We have noticed that the properties of the P2X7R pore
match those of pannexin1 channels in several respects. Com-
mon properties include permeability for large molecules and
dyes typically used to analyze gap junction channels, sensitivity
to cytoplasmic acidiﬁcation, single channel conductance, and
sensitivity to gap junction channel blockers [8–11].
We consequently tested whether pannexin1 could represent
the P2X7R pore by manipulating pannexin1 expression in a
human astrocytoma cell line (1321N1 cells) stably expressing
the rat P2X7R and by expressing human pannexin1 and
human P2X7R (in isolation and in combination) in Xenopus
oocytes. Through the use of a variety of approaches (ﬂuores-
cence imaging, electrophysiological recordings, and Western
blotting) we provide evidence that pannexin1 channels are
likely the pore forming units activated by ATP stimulation
of the P2X7R.2. Materials and methods
Cell culture. The human astrocytoma cell line (1321N1) stably
expressing the rat-P2X7 receptor (r-P2X7R) (construct kindly provided
by Dr. AnnMarie Surprenant, Institute of Molecular Physiology, Uni-
versity of Sheﬃeld, UK) was grown in DMEM (Gibco) containing
10% FBS (Gibco) and 1% antibiotics, as previously described [8].
Two days before experimentation, cells were plated in glass-bottomed
(MatTek) dishes for dye-uptake measurements.
siRNA. P2X7R-expressing astrocyoma cells were treated with 1 lg/
1.5 ml small interference RNAs corresponding to the human pann-
exin1 using 6 ll/1.5 ml oligofectamine reagent (Invitrogen). After over-
night exposure, transfection reagents were removed and cells incubated
for 30 h in DMEM-FBS medium. The target sequences for the siRNAs
were: (1) GGCUGCCUUUGUGGAUUCAtt and (2) GGAGAUCU-
CGAUUGGUACAtt for human pannexin1. Target sequences for
mouse pannexin1 were: (1) GGCUGCCUUUGUGGAUUCAtt, (2)
GGAACUUGACAAAGUCUACtt, and (3) GGUGCUGGAGAA-
CAUUAAAtt. Control siRNA ‘‘Silencer Negative’’ 1-3 from
Ambion Inc. (Austin, TX, USA) were used as controls.blished by Elsevier B.V. All rights reserved.
Fig. 1. Pannexin1 mediated P2X7R pore formation in 1321N1 cells.
(a) Bar histogram showing that the expression levels of pannexin1 in
the human astrocytoma cell line stably transfected with the r-P2X7R is
greatly reduced following 48 h transfection of two human pannexin1
siRNA sequences. Mean and standard error ratio values of pannexin1/
GAPDH were obtained from four experiments. Inset shows a
representative Western blot. (b) Bar histograms showing the mean
values of the relative YoPro ﬂuorescence intensity (F/F0) obtained in
P2X7R-astrocytoma cells untreated (control) and treated for 48 h with
pannexin1 siRNA bathed in low divalent cation solution induced by
BzATP (N = 400–600 cells, from four independent experiments). Note
that inﬂux of YoPro was greatly attenuated in cells treated with
pannexin1 siRNA compared to untreated (control) cells. Inset shows
an example of the time course of YoPro ﬂuorescence changes induced
by BzATP.
484 S. Locovei et al. / FEBS Letters 581 (2007) 483–488Dye uptake. r-P2X7R expressing 1321N1 cells were bathed for 5 min
in a low divalent cation phosphate-buﬀered solution (Ca2+-free
DPBS + 1 mM MgCl2 + 1 mM EDTA, pH 7.4) containing the
cell-impermeant (629 Da) dye YoPro-1 (5 lM; a cationic cyanine
monomer that upon binding to nucleic acids exhibits a 1800-fold ﬂuo-
rescence enhancement: Invitrogen-Molecular Probes) and basal ﬂuo-
rescence intensity measured from regions of interest placed on cells.
Cells were then exposed to low divalent cation solution containing
100 lM BzATP and 5 lM YoPro, and dye ﬂuorescence intensity mea-
sured following 5 min stimulation. After background subtraction, Yo-
Pro ﬂuorescence intensity was normalized to values obtained from cells
bathed in low divalent solution containing 5 lM YoPro. Dye ﬂuores-
cence was captured using an Orca-ER CCD camera attached to an in-
verted Nikon microscope equipped with a 20· dry objective and
488 nm ﬁlter set using Metaﬂuor software.
Membrane blebbing. To visualize membrane blebbing induced by
P2X7R activation, 1321N1 astrocytoma cells plated on MatTek dishes
were exposed to the same low divalente cation solution described
above for dye uptake measurements containing the amphiphilic styryl
dye FM4-64 (1 lM ﬁnal concentration; Molecular Probes). Changes in
cell membrane morphology (blebs) induced by 150 lM BzATP, in the
absence and presence of 50 lM carbenoxolone. Images were acquired
at 1 Hz over a period of 2–3 min following the addition of BzATP
using an Orca-ER CCD camera attached to an inverted Nikon micro-
scope equipped with a 40· dry objective and 594 nm ﬁlter set using
Metaﬂuor software. After playback and analysis of the saved images,
the number of cells within the ﬁeld of view displaying membrane blebs
was quantiﬁed and data expressed as fraction of total number of cells.
Three to four independent experiments were performed.
Western blots. After YoPro inﬂux measurements, cells were lysed
with 2· Laemmli buﬀer (containing 100 mM DTT) and subjected to
electrophoresis using SDS–PAGE mini-gels (4–20%; BioRad). Proteins
were transferred to nitrocellulose membranes (Schleider & Schuell) and
after overnight blocking (2% non-dry milk in 1· PBS with 0.05%
Tween-Twenty), membrane were blotted using anti-Pannexin1
(1:2000) [12] and anti-GAPDH (1:5000; Research Diagnostics) pri-
mary antibodies for 2 h at room temperature. After several washes
in 1XPBS-TweenTwenty solution, membranes were incubated for
2 h with rabbit-anti-chicken, and goat-anti-mouse HRP conjugated
secondary antibodies (1:2000). Bands were visualized in X-ray ﬁlms
(Kodak) after incubation with the enhanced chemiluminescent reagent
(Amersham). Quantiﬁcation of pannexin1 expression levels was
performed using NIH-imaging software.
Electrophysiology: Preparation of oocytes and electrophysiological
recording were performed as described [13]. Human pannexin1
(MRS1) was kindly provided by Dr. Graeme Bolger, University of
Alabama and human P2X7R kindly provided by Dr. Annemarie Sur-
prenant, University of Sheﬃeld, UK.
Pannexin1, in Bluescript, was linearized with Kpn I, h-P2X7, in
pcDNA3, with Avr II. In vitro transcription was performed with the
polymerases T3 (pannexin1), and T7 (P2X7R) using the Message
Machine kit (Ambion, Austin, TX, USA). mRNAs were quantiﬁed
by absorbance (260 nm), and the proportion of full-length transcripts
was checked by agarose gel electrophoresis. In vitro transcribed
mRNAs (20 nL) were injected into Xenopus oocytes. The oocytes
were incubated at 18 C for 18–24 h in Oocyte Ringer’s Solution
(OR2) (in mM: 82.5 NaCl, 2.5 KCl, 1 MgCl2, 1 CaCl2, 1 Na2HPO4,
5 HEPES; pH 7.5). ‘‘Calcium free’’ OR2 had the same composition,
except CaCl2 was omitted.
Whole cell membrane current of single oocytes was measured using a
two- microelectrode voltage clamp and recorded with a chart recorder.
Both voltage-measuring and current-passing microelectrodes were
pulled with a vertical Puller (Kopf) and ﬁlled with 3 M KCl. The
recording chamber was perfused continuously with solution. Mem-
brane conductance was determined using voltage pulses, typically of
5 s duration and of 5 mV amplitude.
For dye uptake measurements, oocytes were incubated for 5 min
in OR2 supplemented with 30 lM BzATP and 10 mM carboxyﬂuores-
ceine. After extensive washing oocytes were frozen. Twenty micro-
meters of thick cryosections were mounted on glass slides in 40%
glycerol phosphate buﬀered saline solution and viewed on an epiﬂuo-
rescence microscope. Data were analyzed with NIH image software
program (http://rsb.info.nih.gov/nih-image/). A 50 · 50 lm area be-
neath the plasma membrane was selected and mean ﬂuorescence deter-
mined.3. Results
We have previously shown that the inﬂux of large tracer
molecules following activation of P2X7R was prevented by a
series of compounds typically used as gap junction channel
blockers [8]. These observations raised the possibility that
these gap junction channel blockers could either interfere with
the P2X7 receptor itself and/or interfere with an additional
channel protein recruited by the P2X7R. A non-connexin can-
didate that shares similar pharmacological properties to gap
junction channels is the pannexin1 channel.
To test whether pannexin1 is involved in P2X7R-mediated
membrane permeabilization, we used the human astrocytoma
cell line 1321N1 stably expressing the rat P2X7R. First, we
siRNA
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Fig. 2. Expression of pannexin1 in astrocytes. Western blot of lysates
of primary cultures of mouse cortical astrocytes after treatment with
siRNA to three diﬀerent targets in mouse pannexin1 and with three
diﬀerent control siRNAs were performed. Beta tubulin was used to test
for uniformity of loading.
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exin1. Western blot analysis indicated that these cells expressed
low levels of pannexin1 (Fig. 1a); moreover, 48 h treatment
with two small interference RNA (siRNA) targeting human
pannexin1 greatly reduced pannexin1 levels (Fig. 1a). Similar
results were obtained for primary cultures of mouse cortical
astrocytes (Fig. 2). In the next set of experiments, P2X7R
expressing astrocytoma cells were treated with the two pann-
exin1 siRNA sequences to measure BzATP-induced YoPro up-
take. As shown in Fig. 1b, downregulation of human
pannexin1 by siRNA signiﬁcantly reduced YoPro uptake com-
pared to untreated cells. These data, therefore, suggest that
pannexin1 is likely to contribute to membrane permeabiliza-
tion that occurs after activation of the P2X7R. That the inhi-
bition by siRNA of pannexin1 protein level was moreP2X7 Pan
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Fig. 3. Membrane currents from oocytes expressing rat P2X7R or co-expres
was clamped at 50 mV and 5 mV depolarizing pulses were applied (top trac
considerably larger in co-expressing oocytes than in oocytes expressing P2X7
oocytes expressing P2X7R alone or in combination with Panx1. (n = 5). (c)
conductance (triangle) induced by BzATP. Data were normalized to values
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Fig. 4. Membrane currents and morphology of oocytes co-expressing P2X7
200 lM ATP resulted in a reversible inward current. Longer exposure to 5
subsequently increased to levels that could not be clamped anymore, indicati
quadrant) and oocytes co-expressing P2X7R and Panx1 (lower right quadran
pigmentation was observed in the co-expressing but not in the control oocytes
out of the cells. A video clip of this sequence of events is shown in Supplempronounced than the inhibition of BzATP-induced YoPro up-
take can have several explanations. For example, pannexin
protein in diﬀerent cellular compartments may have diﬀerent
turnover rates or channel kinetics may change with expression
levels. Alternatively, the residual YoPro uptake may be
through unspeciﬁc leakage or through a speciﬁc, yet unidenti-
ﬁed alternate pathway.
To further verify the hypothesis that pannexin1 is part of the
P2X7R permeabilization pore, electrophysiological and dye
uptake studies were performed in Xenopus oocytes expressing
the human P2X7R and human pannexin1. As shown in
Fig. 3a, ATP (200 lM) induced an inward current in oocytes
expressing P2X7R (middle trace), but not in non-transfected
oocytes (not shown). Also, as shown previously (11), ATP as
high as 500 lM does not induce pannexin currents in oocytes
expressing pannexin1 only. Co-expression of P2X7R and pann-
exin1 increased the inward current (bottom trace) as compared
to oocytes expressing only the receptor. Quantiﬁcation of
ATP-induced currents indicates that co-expression of the two
proteins led to a sixfold increase in inward current (from
0.5 lA in P2X7R to 3 lA in P2X7 + pannexin1; Fig. 3b). The
dose–response curve for the P2X7R agonist BzATP is shown
in Fig. 3c. The concentration dependence of the currents in-
duced by the agonist was the same in oocytes co-expressing
the receptor with pannexin1 as has been documented for the
human P2X7R receptor [14]. However, the currents in the
co-expressing cells were considerably larger than in oocytes0.1 1 10 100 1000
0
25
50
75
100
total current
conductance
Bz ATP (μM)
x1+P2X7
c
sing the receptor with human pannexin 1. (a) The membrane potential
e). Application of 200 lM ATP resulted in inward currents, that were
R alone. (b) Mean ATP-induced (200 lM) peak membrane currents in
Dose–response curve of membrane currents (squares) and membrane
obtained with the highest BzATP concentration tested (200 lM).
c d
R and Panx1 with prolonged exposure to ATP. (a) Brief exposure to
00 lM ATP resulted in a current that initially reversed partially but
ng membrane breakdown. (b) Non-injected control oocytes (upper left
t) were exposed to 300 lMATP. (c) Within 3 min a dramatic change of
. (d) After 5 min all co-expressing oocytes sprang leaks with yolk oozing
ent 1.
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of P2X7R resulted in the opening of additional, presumably
pannexin1 channels.
In cells expressing only P2X7R and in those co-expressing
the receptor with pannexin1 the higher concentrations of the
agonist resulted in changes of the pigment distribution, most
likely as a consequence of the associated calcium inﬂux. Typi-
cally, this change remained inconsequential for the membrane
integrity of oocytes expressing the receptor alone. In contrast,
the co-expressing oocytes exhibited a breakdown of membrane
resistance (Fig. 4a) and yolk could be observed oozing from
the cells under these conditions (Fig. 4b–d and Supplement
1). It appears that the death signaling observed in macro-
phages exposed to ATP can be reconstituted in oocytes coex-
pressing P2X7R and pannexin1. Carbenoxolone delayed the
onset of cell death but did not block it. The failure of complete
inhibition of cell death probably is due to the high expression
levels of the proteins in combination with the inability of
carbenoxolone to close pannexin1 channels completely. To
further address this issue, P2X7R-expressing 1321N1 astyro-
cytoma cells were tested for an eﬀect of carbenoxolone on cell
membrane blebbing induced by BzATP (150 lM). As shown in
Supplement 2 carbenoxolone (50 lM) suppressed membrane
blebbing, which is an early symptom of cell death.
Fig. 5a shows currents induced by 200 lM ATP in oocytes
expressing the human P2X7 receptor. As described by others
[15,16] the currents desensitize during ATP application and
desensitization outlasts the stimulus as repeated applications5 min
1 μA
ATP
ATPCBX / ATPATP
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Fig. 5. Membrane currents induced by 200 lM ATP in oocytes
expressing P2X7R alone (a and b) or co-expressing P2X7R with Panx1
(c). ATP was applied to each oocyte three times as indicated by the
bars. Due to desensitization, the currents progressively became
smaller. Inclusion of the pannexin channel inhibitor carbenoxolone
(100 lM) did not change this pattern in oocytes expressing P2X7R
alone (b and inset). However, in oocytes co-expressing P2X7R with
Panx1 the inclusion of carbenoxolone attenuated the ATP induced
currents so that the subsequent application of ATP resulted in larger
currents. (d) Quantitative analysis of the currents normalized to the
ﬁrst ATP response. Means ± S.E. are plotted (n = 4).result in smaller amplitude currents. Inclusion of the gap junc-
tion channel blocker carbenoxolone did not change this pat-
tern (Fig. 5b), indicating that the drug does not act directly
on P2X7R. Co-expression of P2X7R with pannexin1 yielded
considerable larger currents in response to ATP stimulation
(Fig. 5c). The currents desensitized as in oocytes expressing
P2X7R alone. In contrast, in carbenoxolone treated co-
expressing cells, the ATP induced currents were attenuated.
Fig. 5d shows a quantitative analysis of the carbenoxolone ef-
fect.
Flufenamic acid, another gap junction blocker, also has been
shown to inhibit ATP-induced dye uptake in astrocytes [8].
However, in contrast to carbenoxolone, ﬂufenamic acid ap-
pears to exert its inhibitory action at more than one target.
As shown in Supplement 3, 100 lM ﬂufenamic acid attenuated
the ATP-induced currents in oocytes expressing P2X7R alone.
In oocytes expressing exclusively pannexin1 ﬂufenamic acid
inhibited the voltage-activated pannexin1 channels (Supple-
ment 4). However, higher concentrations (300 lM) were re-
quired to observe signiﬁcant eﬀects. This is in line with the
inhibition of pannexin1 channels by ﬂufenamic acid reported
earlier [9].
To activate pannexin1 channels by voltage the membrane
must be depolarized to positive values [10,17]. However, acti-
vation of pannexin1 channels through P2X7R stimulation oc-
curred at the cell’s resting membrane potential. At resting
potential, pannexons have been reported to be activated by in-
creases in cytoplasmic calcium concentration [11]. It is there-
fore feasible that the calcium permeability of the non-
selective cation conductance could account for pore formation
in oocytes co-expressing pannexin1 and P2X7R. On the other
hand, pore formation by P2X7R in macrophages and other
cells is reported to be facilitated by low extracellular calcium
concentration [6]. To test for extracellular calcium involvement
in pannexin1 activation through P2X7R, activation of pann-
exin1 channels by ATP exposure was studied in calcium-free
(no calcium added) oocyte Ringer solution. Removal of extra-
cellular calcium did not abolish pannexon activation through
P2X7R, 20 lM BzATP still elicited large currents that were
attenuated by carbenoxolone in oocytes co-expressing Panx1
and P2X7R (Fig. 6).
To gather further support for the hypothesis that pannexin1
channels provide membrane permeabilization following
P2X7R activation, carboxyﬂuorescein uptake was evaluated
in oocytes expressing the receptor alone and in combination
with pannexin1. As indicated in Fig. 7, expression of P2X7R1 μA
2 min
BzATP CBX/BzATP BzATP
Fig. 6. Membrane currents induced by 20 lM BzATP in oocytes co-
expressing P2X7R with Panx1. Like in normal Ringer solution,
carbenoxolone (CBX, 100 lM) attenuated the currents in ‘‘calcium-
free’’ (no calcium added) Ringer solution.
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Fig. 7. Uptake of carboxyﬂuoresceine in oocytes. Non-injected control
oocytes, oocytes expressing P2X7R alone or Panx1 alone, and oocytes
co-expressing P2X7R and Panx1 were exposed for 5 min to Ringer
solution supplemented with 10 mM carboxyﬂuoresceine and 30 lM
BzATP. Fluorescence was determined on cryosections and was
normalized to the values observed in control oocytes.
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agonist stimulation, but when co-expressed with pannexin1, a
threefold increase in ﬂuorescence intensity was recorded. Thus,
these data support the hypothesis that recruitment of another
protein, most likely pannexin1, is necessary for P2X7R to pro-
vide membrane permeability to large molecules.4. Discussion
P2X receptors are ionotropic receptors that open Ca2+ per-
meable channels when activated by pyrimidine nucleotides.
However, during prolonged exposure to agonists, certain of
these receptors (P2X2, P2X4, P2X5 and P2X7) can lead to the
formation of permeabilizing pores, allowing the passage of
large molecules (North, 2002).
Expression of cloned P2X7R in mammalian cells led to up-
take of moderately large ﬂuorescent dyes upon exposure to
P2X receptor agonists [4], as had been reported for ATP acti-
vation of the permeabilizing pore (formerly known as the P2Z
receptor) [18–21]. However, this property has not yet been ob-
served in P2X7-RNA injected Xenopus oocytes [6,22], although
when macrophage mRNA is co-injected, oocyte permeabiliza-
tion occurs [7]. This ﬁnding, together with the observations
that the permeability of these ‘‘pores’’ to large molecules, var-
ies among mammalian cell types [5] led to the conclusion that
another ‘‘factor’’ was required to provide P2X7R with the P2Z
property. Since then, two distinct hypotheses have been pro-
posed to account for the transformation of P2X7R permeabil-
ity from cationic channel to conduit for ﬂuorescent molecule
ﬂux that occurs upon prolonged agonist activation. One is
based on the idea that incorporation of multiple P2X7R sub-
units confer successive increases of permeability to large mole-
cules [23–25]; the other hypothesis considers the existence of
another independent channel permeable to large molecules
[22,26–28] that is recruited following P2X7R activation by
means of an intracellular signaling cascade [29].
P2X7R pore formation has been reported to be dependent
on the carboxyl terminal cytoplasmic segment of P2X7R. After
removal of this segment, pore formation is lost while the cation
permeability remains unaltered [14,30], and several intracellu-
lar binding partners have been identiﬁed [31], that could pro-
vide a link between the receptor itself and the pore. Becausepore formation rate is inversely related to extracellular calcium
concentration [24,32], it is likely that the inﬂux of calcium is
not a crucial factor in pore formation (but see [29]).
Pannexins are a new group of proteins that share low homol-
ogy with invertebrate gap junction proteins, the innexins
[33,34]. When expressed in Xenopus oocytes, pannexin 1 and
2 have been reported to form gap junction channels and also
to function as hemi-gap junction channels that are sensitive
to gap junction channel blockers, including carbenoxolone
[9,17]. Gap junction channel formation by pannexins in vivo,
however, remains to be demonstrated [35].The non-junctional
pannexin1 channels are voltage sensitive, 400pS channels that
are modulated by intracellular calcium and by mechanical
stretch [10,11]; these large conductance channels have been
proposed to mediate ATP release from erythrocytes [12].
Interestingly, we have previously reported that P2X7 recep-
tors are likely involved in ATP release from astrocytes, and
have shown that gap junction channel blockers interferes with
P2X7R activity. [8]. These ﬁndings, however, did not discrim-
inate between the possibility that these blockers either interfere
with the P2X7 receptor itself or that the P2X7R mediated ef-
fects involved an additional channel protein that is targeted
by the blockers. Consistent with the latter, the P2X7 receptor
is not a stand-alone channel, but a signaling complex [31].
To discriminate between these possibilities, we tested the eﬀects
of the gap junction channel blocker carbenoxolone and FFA
on currents in Xenopus oocytes expressing P2X7R alone or
co-expressing the receptor with pannexin1. The results indicate
that pannexin rather than P2X7R is aﬀected by carbenoxolone,
while FFA acts on both P2X7 receptor and pannexin.
The involvement of pannexin1 in dye uptake/ATP release is
also supported by the interference of pannexin1 speciﬁc siRNA
in the human astrocytoma cell line 1321N1 stably expressing
the rat P2X7R. Recently, a similar suppression by pannexin1
siRNA was reported for dye uptake in macrophages [36].
However, inexplicably, no current associated with pannexin1
was found in that study. Furthermore, a great portion of the
evidence for a pannexin1 involvement was based on a ‘‘pann-
exin mimetic peptide’’ whose speciﬁcity was not documented.
The activation of pannexin1 could occur through protein–
protein interaction or through calcium as second messenger.
Initial binding of ATP to P2X7 receptors leads to a non-spe-
ciﬁc cation permeability facilitating the inﬂux of calcium
among other cations. Pannexin1 channels can be activated
by micromolar cytoplasmic calcium [11]. However, consistent
with ﬁndings in macrophages, where pore formation is inde-
pendent of extracellular calcium, it appears that calcium inﬂux
is not required for pannexin1 activation through P2X7 recep-
tors. The activation may thus occur through protein–protein
interaction. Such an interaction between P2X7 and pannexin1
in macrophages is indicated by the co-immunoprecipitation of
the two proteins by a P2X7 antibody [36].
It appears that pannexin1 is promiscuous in its interactions
with purinergic receptors. In addition to the activation through
P2X7 receptors shown here it can, at least in oocytes, also be
activated by ATP through the metabotropic receptors P2Y1
and P2Y2 [11]. Thus, intercellular calcium signaling may in-
volve pannexin1 channels in combination with either P2X7
or P2Y receptors. Calcium wave initiation could be exclusively
mediated by pannexin1 due to its channel properties, which in-
clude mechanosensitivity and high ATP permeability. Wave
propagation on the other hand requires an ATP receptor in
488 S. Locovei et al. / FEBS Letters 581 (2007) 483–488addition to an ATP release channel. Pannexin1 in combination
with either P2Y or P2X7 receptors may serve this function.
Both types of receptors when activated by ATP can open
pannexin1 channels as shown here for P2X7 and previously
for P2Y1 and P2Y2 [11]. The question that remains to be fur-
ther investigated, however, is why activation of P2X7R but not
of metabotropic P2YR leads to membrane permeabilization.
With the detection of pannexin1 in astrocytes, the list of
ATP releasing cells also expressing pannexin1 is growing.
The list includes erythrocytes that express this ‘‘gap junction
protein’’ without ever forming cell–cell junctions.
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